FindTrial
Sign In

Impact of anxiety on the effective dose of esticketamine for preventing propofol injection pain in patients with painless induced abortion

Impact of anxiety on the effective dose of esticketamine for preventing propofol injection pain in patients with painless induced abortion

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060873
Enrollment
Unknown
Registered
2022-06-13
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

propofol injection pain

Interventions

anxiety group:esketamine
comtrol group:esketamine

Sponsors

Ningbo Women and Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.these women scheduled for painless abortion 2.aged 20 to 40 years 3.ASA physical status?or ? 4.BMI 19-26 kg/m2 5.Mallampati status?or ?

Exclusion criteria

Exclusion criteria: 1.Subjects with severe risk of hypertension, elevated intraocular or intracranial pressure; 2.Subjects with hyperthyroidism; 3.Subjects with neurological or psychiatric disorders; 4.Subjects with severe allergic or hyper sensitivity reaction to Ketamine or propofol 5.Subjects with addiction to opioids or other drugs.

Design outcomes

Primary

MeasureTime frame
ED50;ED95;—

Secondary

MeasureTime frame
dosage of propofol;adverse events;—

Countries

China

Contacts

Public ContactShen Yanping
3261438629@qq.com+86 13586542013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026